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Supplementary 
prescribing: Patient, 
podiatrist and 
professor perspectives
O
ver the past 20 years, the healthcare 
work force has been transformed. For 
eligible allied healthcare professions, 
non-medical prescribing has been introduced. 
This  move  has  given  fast  and  safe  access  to 
appropriate medicines for a range of patients.
Supplementary  prescribing  rights  were 
extended  to  include  the  podiatry  profession 
in  2005,  but  few  podiatrists  have  taken  on 
this  role.  At  present,  around  just  120  UK 
podiatrists  are  qualified  supplementary 
prescribers  (Health  Professions  Council, 
2010). With so few practising supplementary 
prescribers  in  podiatry,  it  is  perhaps 
unsurprising that their impact – on the health 
service, patient care and, ultimately, outcomes 
– may be considered minimal. 
So  what  are  the  benefits  of  non-medical 
prescribing, and what value does it add to the 
health  service?  More  specifically,  how  does 
supplementary  prescribing  improve  outcomes 
in the management of people with long-term 
conditions,  such  as  diabetes  and  diabetes-
related complications of the foot?
Here, the authors offer various perspectives 
– that of the patient (Umberto Saoncella), the 
physician  (Philip  Wiles)  and  the  podiatrists 
(Louise Stuart, Martin Fox) – on the benefits 
of  supplementary  prescribing.  In  conclusion, 
Alan  Borthwick  looks  at  the  possibilities  of 
independent prescribing for podiatrists and at 
the  projects  that  are  currently  under  way  to 
determine the best path forward.
Background
The  vast  majority  of  podiatrists  access 
medicines  for  their  patients  via  statutory 
exemptions,  Patient  Group  Directions  or 
rely  on  prescriptions  written  by  medical 
colleagues.  Those  who  have  successfully 
undertaken  the  supplementary  prescriber 
course can prescribe medicines for a patient 
within  an  agreed  clinical  management 
plan  between  reviews  by  the  independent 
prescriber  –  most  often  a  physician. 
Podiatrists  are  not  yet  able  to  prescribe 
independently, unlike appropriately qualified 
nurses  and  pharmacists  (Department  of 
Health, 2006).
The	patient’s	perspective
Umberto Saoncello has been receiving care 
for  active  Charcot  foot  disease  and  foot 
ulceration for the past 3 years in Manchester. 
During this time he has regularly attended 
the hospital-based multidisciplinary diabetic 
foot  team,  which  includes  a  podiatrist 
supplementary  prescriber.  When  asked  to 
comment on his experiences he said:
“The diabetic foot clinic has been a beacon 
of hope for me over the past 3 years. Before 
being managed in the clinic, I struggled to 
obtain specialist care for my foot problems. 
In  the  past  2  years  I  have  swiftly  received 
antibiotics,  prescribed  by  my  podiatrist,  as 
well  as  my  diabetologist,  when  they  have 
been needed.
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“It seems logical to me as a patient that a 
podiatrist  prescriber  offers  joined-up  care.  I 
fail to understand why, at the most important 
juncture of my care, the pen could be taken 
from the hand of the person who knows me 
best  and  thrust  into  the  hand  of  another 
professional  who,  in  some  cases,  may  know 
little about my condition.
“I was dealt with competently, kept informed 
of all aspects of my care and had full confidence 
in  the  podiatrist  prescribing  for  me.  There 
was  a  totality  of  care  given,  not  fragmented 
management. My GP was kept fully informed 
of my treatment and continued to prescribe in 
the community in line with advice given by the 
podiatrist and my diabetologist.
“I  would  argue  that  people  with  diabetes-
related  foot  problems  need  more  specialists 
able  to  prescribe  medicines  appropriately   
in  all  locations,  not  just  hospitals.  At 
times,  my  care  –  particularly  outside  of  the   
hospital  –  has  not  been  provided  by  those 
sufficiently knowledgeable or skilled to manage 
my foot problems.”
The	professor’s	perspective
Philip Wiles is Honorary Professor, University 
of  Salford  and  a  jobbing  general  diabetes 
consultant working in a large district general 
hospital  diabetes  centre.  Having  mentored 
and  worked  with  both  independent  and 
supplementary prescribers, Philip had this to 
say on his experiences: 
“By  far  the  greatest  impact  made  by  the 
introduction of supplementary prescribing at our 
hospital has been on the diabetic foot service. In 
that environment clinical problems are dynamic 
and the pace frequently frenetic, making non-
medical  prescribing  completely  practical.  As 
a  result,  clinics  run  more  smoothly  and  the 
patients leave for home more quickly. 
“Supplementary prescribing is underpinned by 
a robust governance process that applies structure 
and  scrutiny  to  prescribing.  Best  practice  has 
extended into the community, and I have seen a 
more rational approach to antibiotic prescribing 
in  primary  care  settings  as  a  consequence  of 
contact with a prescribing podiatrist.
“Personally,  I  have  benefited  from  the  case 
discussions and the need to explain prescribing 
decisions.  Supplementary  prescribing  has  also 
released  some  of  my  time  to  spend  on  other 
aspects  of  patients’  general  care  and  diabetes 
management.
“Podiatrists  cannot,  as  yet,  prescribe 
independently.  Supplementary  prescribing 
is  fine  within  a  clinic  environment,  but  the 
lack  of  independence  is  a  hindrance  when 
trying  to  manage  foot  ulceration  in  the 
community.  Neither  my  podiatry  colleagues 
nor  our  patients  have  the  luxury  of  time  to 
waste. I look forward to the extension of full 
independent prescriber status to appropriately 
trained podiatrists.”
The	prescribing		
podiatrists’	perspective
Louise  Stuart  and  Martin  Fox  describe 
the  supplementary  prescribing  course  for 
podiatrists as the most useful one they have 
undertaken since qualifying. If readers think 
that writing a prescription is the only benefit, 
they urge them to think again:
“Penning the prescription is the tip of the 
iceberg; we review medicines in every patient 
we see. This allows us to provide a safer and 
more informed and holistic service for people 
with  diabetes-related  foot  complications. 
But  apart  from  our  anecdotal  experiences, 
what  evidence  is  there  that  supplementary 
podiatrist prescribers add value to the health 
service  and  improve  patient  experience  and 
outcomes?
“In 2009, the North-West Allied Healthcare 
Professions Non-Medical Prescribing Network 
(AHP  NMP)  undertook  an  audit  of  allied 
healthcare  professional  prescribing  practices. 
To the best of our knowledge, it is the largest 
audit of its kind. The aim was to assess the 
impact  of  supplementary  prescribing  on 
patient care.
“The  AHP  NMP  audit  revealed  the 
immediate  access  to  medicines  provided  by 
non-medical prescribing, with a prescription 
being  drawn  in  80%  of  all  emergency 
appointments.  The  follow-on  effect  of  this 
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is the prompt treatment for the patient, the 
prevention  of  referrals  and  a  cost  saving  to 
hospital-based  emergency  care  that  would 
otherwise have been engaged.
“The  audit  also  revealed  that  a  review  of 
patients’  medicines  took  place  in  97%  of 
cases.  The  impact  of  the  medicines  review 
led  to  the  recognition  of  sub-therapeutic 
doses  and  inappropriate  regimens,  which 
were subsequently red-flagged to independent 
prescribers.  In  one  in  ten  cases  the  non-
medical  prescriber  identified  inappropriate 
repeat prescriptions, the correction of which 
would result in cost saving and a reduction in 
medicines waste.
“Few  studies  have  critically  examined  the 
impact  of  non-medical  prescribing  and  in 
the  absence  of  evidence,  the  effectiveness 
of  prescribing  is  assessed  by  the  surrogate, 
and  less  than  ideal,  measure  of  number  of 
prescriptions issued. The assumption that the 
success of non-medical prescribing lies in the 
number of prescriptions written was refuted 
by the AHP NMP audit. There are multiple 
benefits to prescribing, not only in improved 
patient care but also in terms of ensuring the 
appropriate use of scarce NHS resources.”
Independent	prescribing:	
The	way	forward?
In its report of July 2009, the Department of 
Health’s Allied Health Professions Prescribing 
and  Medicines  Supply  Mechanisms  Scoping 
Project  recommended  two  additional 
implementation  phases  designed  to  enhance 
access  to  and  up-take  of  non-medical 
prescribing across a range of allied healthcare 
professions.  In  February  2010,  the  Allied 
Healthcare  Professions  Medicines  Project 
was established with a view to enacting the 
first of the two recommended phases and is 
presently preparing for public consultation on 
extending  the  independent  prescriber  status 
to the podiatry and physiotherapy professions. 
Although  there  has  been  unavoidable 
uncertainty around the policy priorities of the 
new Coalition Government, the work of the 
project continues apace.
As was the case in nursing, pharmacy and 
optometry,  a  range  of  prescribing  activity 
options are being considered for podiatrists. 
Would  limited  prescribing  within  a  set 
formulary be sufficient, or would freedom to 
prescribe where relevant be preferable? Might 
it  be  effective  to  prescribe  within  a  limited 
range of conditions, or would this create more 
problems for patients than even the current 
system allows?
Answers  to  these,  and  related,  questions 
will  determine  the  case  for  independent 
prescribing status for the podiatry profession. 
As  evidence  grows  that  supplementary 
prescribing  benefits  patients,  makes  services 
more  responsive  and  reduces  the  burden 
on  GPs  and  hospital  physicians,  the  case 
for  independent  prescribing  status  for  the 
podiatry profession will strengthen.  n
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